Already a member? Sign in
Category: Others
R(+) pramipexole dihydrochloride monohydrate [R(+)PPX], an experimental neuroprotective drug, is provided in this open label extension study to ALS patients who have participated in earlier clinical protocols.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| ALS (Amyotrophic Lateral Sclerosis) | 3 | 0 | |||||
| Other | 1 | 0 |
See all 2 patients currently using ALS Phase 2 Study KNS-760704
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 1 |
See all 1 patient who’ve stopped using ALS Phase 2 Study KNS-760704
Report created on February 11, 2012.